Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab

Fig. 1

Flowchart of the study. a Retrospective cohort samples were taken from Mariotte D. 2011 study [17]. b Prospective cohort samples were taken from Dupont B.2017 study [11]. A randomized selection of 95 out of 247 patients was performed. Severity grades refer to Ring and Messmer scale [18]. Abbreviations: HSR, Hypersensitivity Reaction; IQ, Insufficient Quantity. * Anaphylactic hypersensitivity reaction based on clinical criteria

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us